Nisa Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.9K Sell
1,020
-1,216
-54% -$52.2K ﹤0.01% 1864
2026
Q1
$84.9K Buy
2,236
+734
+49% +$34.8K ﹤0.01% 1487
2025
Q4
$76.4K Sell
1,502
-198
-12% -$10.1K ﹤0.01% 1514
2025
Q3
$94.3K Buy
1,700
+500
+42% +$29.3K ﹤0.01% 1459
2025
Q2
$82.8K Buy
1,200
+300
+33% +$20.4K ﹤0.01% 1456
2025
Q1
$63.5K Sell
900
-600
-40% -$49.6K ﹤0.01% 1523
2024
Q4
$129K Buy
1,500
+400
+36% +$43.3K ﹤0.01% 1402
2024
Q3
$131K Sell
1,100
-300
-21% -$40K ﹤0.01% 1372
2024
Q2
$200K Buy
+1,400
New +$186K ﹤0.01% 1307

Other funds holding NVO

Nisa Investment Advisors's NVO Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Novo Nordisk (NVO) stake by 54% in Q2 2026, selling an estimated $52.2K and leaving 1,020 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Nisa Investment Advisors first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $200K in Q2 2024. 884 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Nisa Investment Advisors held 1,020 shares of Novo Nordisk worth $48.9K as of Q2 2026.
  • Nisa Investment Advisors sold 1,216 Novo Nordisk shares in Q2 2026, an estimated $52.2K.
  • Novo Nordisk made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1864 holding.
  • Nisa Investment Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Novo Nordisk position peaked at $200K in Q2 2024.
  • 884 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.